Sutro Biopharma STRO Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's common stock?
- Sutro Biopharma (STRO) reported common stock of $17K in Q1 2026.
- How has Sutro Biopharma's common stock changed year-over-year?
- Sutro Biopharma's common stock decreased by 79.8% year-over-year, from $84K to $17K.
- What is the long-term trend for Sutro Biopharma's common stock?
- Over 5 years (2020 to 2025), Sutro Biopharma's common stock has grown at a -27.8% compound annual growth rate (CAGR), from $46K to $9K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).